ArticleFrontiers in immunology2026

Multicenter real-world data on immunotherapy for R/M HNSCC from China: comprehensive analysis of efficacy and survival differences across diverse clinical backgrounds, and identification of predictive peripheral blood biomarkers.

Feifan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.